Test Price
2,800 AED✅ Home Collection Available
MECP2 Gene (Neonatal Severe Encephalopathy) Genetic Test in UAE | 2800 AED | 2026 DHA Guidelines
تحليل جين MECP2 للإعتلال الدماغي الوليدي الشديد بتقنية التسلسل الجيني المتقدم (NGS) في الإمارات | 2800 درهم | معتمد من هيئة الصحة بدبي
✅ 99.9% Diagnostic Sensitivity – ISO 9001:2015 Accredited Processing
Premium Logistics: Paid Hospital‑Grade Home Collection via ISO‑Certified Cold‑Chain Home Collection & VIP Mobile Phlebotomy (8 AM – 11 PM).
Clinical Guidance: Telephonic Post‑Test Clinical Guidance for result interpretation.
Insurance: Direct Billing Verification via WhatsApp at +971 54 548 8731.
الملخص التنفيذي
دقة تشخيصية تصل إلى 99.9% من خلال معالجة معتمدة وفق معيار ISO 9001:2015. توفر الخدمة سحباً منزلياً على مستوى المستشفيات مع سلسلة تبريد معتمدة، وإرشادات سريرية هاتفية بعد الفحص، وتحققاً مباشراً من التغطية التأمينية عبر الواتساب.
Clinical Overview
MECP2 Gene (Neonatal Severe Encephalopathy) Genetic Test is a next‑generation sequencing assay that screens the entire coding region of the MECP2 gene for pathogenic variants linked to severe early‑onset encephalopathy and related neurodevelopmental disorders. This UAE‑based test delivers a definitive molecular diagnosis in 3–4 weeks, enabling targeted clinical management for affected neonates.
| Feature | Our Test (MECP2 NGS) | Closest Alternative |
|---|---|---|
| Precision | Full gene coverage, >99.9% analytical sensitivity | Targeted mutation panels – limited variants |
| Methodology | Next Generation Sequencing (NGS), LC‑MS/MS validated | Sanger sequencing / fragment analysis |
| Speed | 3–4 Weeks (comprehensive report) | 4–6 Weeks for equivalent depth |
| Clinical Fit | Neonatal Encephalopathy, Rett/Atypical Rett, MECP2 Duplication | Usually limited to known familial mutations |
Physician Insight & Safety Protocol
“This test provides critical molecular insights into severe early‑onset encephalopathy; however, clinical correlation with symptoms and family history is essential. Always consult a specialist for interpretation.”
— Dr. PRABHAKAR REDDY, DHA License No.: 61713011
⚠️ Medication Warning
Do not discontinue prescribed medication without consulting your doctor. This test does not replace ongoing clinical care.
🛑 Exclusion Criteria & Emergency Red Flags
- Exclusion: Inability to provide a blood or FTA card sample; severely unstable neonate where phlebotomy is contraindicated.
- ER Red Flags: Sudden deterioration of consciousness, apnea, or seizures after sample collection – seek immediate emergency care.
- Minors: Sample collection from minors adheres to UAE CDS Law 2026 and requires legal guardian consent.
🔒 UAE Regulatory & Data Privacy Compliance
- Federal Decree‑Law No. 41 of 2024, Article 87 – Patient safety & genetic testing regulations.
- UAE CDS Law 2026 (Minors) – Mandates parental/legal guardian consent for neonatal testing.
- UAE PDPL – Personal Data Protection Law; all genomic data encrypted and stored on‑shore.
- ISO 9001:2015 Certified (Cert: INT/EGQ/2509DA/3139) – Quality management system for diagnostic accuracy.
Patient FAQ & Clinical Guidance
1. What is the MECP2 gene test for neonatal severe encephalopathy?
It is a complete sequencing of the MECP2 gene to identify pathogenic variants causing severe brain dysfunction in newborns – yielding a definitive diagnosis in just 3–4 weeks.
هو فحص تسلسلي كامل لجين MECP2 لتحديد الطفرات الممرضة المسببة لاعتلال دماغي وخيم لدى حديثي الولادة، مما يمنح تشخيصاً قاطعاً في غضون 3–4 أسابيع.
2. How is the sample collected for this test in the UAE?
Sample collection is performed via a painless blood draw or a simple drop on an FTA card, handled by certified phlebotomists during a hospital‑grade home visit.
يتم جمع العينة إما بسحب عينة دم غير مؤلم أو بوضع قطرة دم على بطاقة FTA، عبر ممرضين معتمدين أثناء زيارة منزلية بمستوى المستشفى.
3. What do the results mean and how long does it take?
Results detail the genetic variant found, its clinical significance, and recurrence risk – delivered in a comprehensive report within 3 to 4 weeks, followed by a post‑test consultation.
توضح النتائج الطفرة الجينية المكتشفة وأهميتها السريرية وخطر تكرارها، وتُسلم في تقرير شامل خلال 3–4 أسابيع مع استشارة هاتفية بعد الفحص.
Support & WhatsApp: +971 54 548 8731 | Facility License: 9834453
All services comply with UAE MOHAP/DHA standards. © 2026
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians